“Since the discovery of the endocannabinoid system consisting of cannabinoid receptors, endogenous ligands, and biosynthetic and metabolizing enzymes, interest has been renewed in investigating the promise of cannabinoids as therapeutic agents.
Abundant evidence indicates that cannabinoids modulate immune responses.
An inflammatory response is triggered when innate immune cells receive a danger signal provided by pathogen- or damage-associated molecular patterns engaging pattern-recognition receptors.
Toll-like receptor family members are prominent pattern-recognition receptors expressed on innate immune cells.
Cannabinoids suppress Toll-like receptor-mediated inflammatory responses.
Innate immune cells express cannabinoid receptors and produce endogenous cannabinoids.
Hence, innate immune cells may play a role in regulating endocannabinoid homeostasis, and, in turn, the endocannabinoid system modulates local inflammatory responses.
Studies designed to probe the interaction between the innate immune system and the endocannabinoid system may identify new potential molecular targets in developing therapeutic strategies for chronic inflammatory diseases.
This review discusses the endocannabinoid system and Toll-like receptor family and evaluates the interaction between them.”